DeepHealth, a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), develops AI-powered health informatics and cloud-native platforms for radiology and medical imaging.
DeepHealth is a health informatics company that applies artificial intelligence to radiology. It develops solutions covering the whole radiology continuum, from disease detection and assessment through monitoring and treatment planning. The company is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and operates globally, with deployments at more than 300 sites.
Its product line is built around DeepHealth OS, a cloud-native operating system designed to unify clinical and operational data and to configure AI-assisted workspaces for different roles across a radiology practice. Alongside this sit two further groups: Enterprise Imaging, comprising the Diagnostic Suite, Operations Suite and TechLive, and a set of Population Health suites tailored to breast, prostate, chest and thyroid, and neuro imaging. Technical work spans machine learning, medical imaging, cloud-native platforms, clinical workflow automation, data interoperability and population health analytics, and the company holds FDA clearances for a number of its AI applications.
Scale is clearest in breast imaging: the Breast Imaging Suite supports more than 10 million mammograms a year, and landmark studies published in Nature Health reported a 21% increase in breast cancer detection rates. The company describes its work as evidence-based and research-oriented, with a stated aim of improving both clinical accuracy and operational efficiency for everyone in the radiology ecosystem.
